Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Integrating new treatment paradigms in breast cancer care in 2019

HR-positive advanced breast cancer: CDK4 inhibitors, who and when

Date

22 Nov 2019

Session

Integrating new treatment paradigms in breast cancer care in 2019

Presenters

Shom Goel

Authors

S. Goel

Author affiliations

  • Medical Oncology, Dana-Farber Cancer Institute, 02215 - Boston/US
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings